Johnson & Johnson said Monday it would pay $480 million for medical device maker Micrus Endovascular, adding a range of treatments for stroke and brain aneurysms.
The deal is expected to close during the second half of 2010.
Micrus, based in San Jose, Calif., focuses on devices aimed at treating stroke and aneurysms. Revenue reached $91.1 million in the fiscal year ended in March.
Most of Micrus' products to treat and prevent nonembolic strokes are manufactured in Miramar, where the company has an undisclosed number of administrative, manufacturing, research and development employees.
Latest from Today's Medical Developments
- Boston Scientific to acquire Penumbra, expanding cardiovascular portfolio
- Star Cutter introduces Double Pilot Reamer
- #80 Manufacturing Matters - Machining Strategies to Save Time and Improve your Process for MedTech Components with Kennametal Inc.
- Real-world parts and expert manufacturing advice
- Experts discuss the latest in toolholding technology
- How permanent magnets are powering medical innovation
- Forecasting the year ahead in design and manufacturing
- Tecomet, Orchid Orthopedic Solutions announce merger agreement
